Skip to main content
Default Image

Obama’s Visit Raises Ghosts of Hiroshima

Our co-founder Gar Alperovitz has been a leader of the conversation about the atrocities of Hiroshima and Nagasaki for decades. Here, he is cited by New York Times journalist David Sanger for his evidence that dropping the bomb was an unnecessary part of the Japanese surrender and the end of World War II:

“The top American military leaders who fought World War II, much to the surprise of many who are not aware of the record, were quite clear that the atomic bomb was unnecessary, that Japan was on the verge of surrender, and — for many — that the destruction of large numbers of civilians was immoral,” Gar Alperovitz, a leader of the movement to revise the United States’ own historical accounting, wrote last year in The Nation… Read full article.

Publication date: 2016-05-09
Parent publication: The New York Times
Publication URL: http://www.nytimes.com/2016/05/11/world/asia/hiroshima-atomic-bomb.html?_r=0

More related work

March 19, 2020
Default Image

Protect the vulnerable, advance the democratic economy: Our statement on the COVID-19 crisis

We are in a period of breakdown, in which all that is wrong with the current system is now being laid bare. Rather than rebuild what we now clearly see should never have been, we must lead the construction out of this crisis of something new.

read more
March 18, 2020
Default Image

HAN Public Comments on Fair Housing Act Proposed Changes

The Healthcare Anchor Network submitted public comments to the Department of Housing and Urban Development (HUD), expressing our opposition to HUD’s proposed changes to the 2015 Affirmatively Furthering Fair Housing rule.

read more
March 17, 2020
An array of prescription medications on shelves

Online press briefing: Vaccines—The COVID-19 Case for Public Pharmaceutical Research and Development

Leading experts believe that it is the government’s responsibility to ensure widespread access to safe and effective vaccines that are developed with taxpayer money. In this virtual press briefing, hear why the U.S. government should develop and manufacture vaccines and other essential medicines so that we get the medicines we need, when we need them and at prices we can afford.

read more